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The endothelial transfer constant, K trans , is an indirect measure of microvascular permeability that has been studied in cerebral diseases. 7 The application of K trans derived from the pharmacokinetic model to acute stroke studies has not been fully investigated. 8 In this study, we conducted a longitudinal follow-up study of K trans on the basis of first-pass T2*-weighted (fpT2*-) perfusion imaging and CET1-WI in patients with acute ischemic stroke and early reperfusion. Because early BBB derangements have been reported linking to reperfusion and a more severe BBB opening would lead to HT, 9 it would be interesting to know if the changes of K trans are related to the PE on CET1-WI and to the subsequent HT in acute stroke. Therefore, the purposes of this study are to evaluate longitudinal changes of K trans , cerebral blood volume, and CET1-WI in acute middle cerebral arterial infarct, and to correlate K trans changes of the acute infarcts with subsequent HT.
Materials and Methods
For a detailed description of methods and statistical analysis, please see the online-only Data Supplement.
We included 26 patients who had acute stroke undergoing ≥3 MR follow-up perfusion-weighted imaging and CET1-WIs at acute, subacute, and chronic stages. There were 101 MR examinations collected from the 26 patients; 7 were obtained at the hyperacute stage (<6 hours after symptom onset); 15 were obtained at the acute stage (6-48 hours after symptom onset); 19 at the early subacute stage (3-4 days after symptom onset); 19 at the late subacute stage (7-9 days after symptom onset); 18 at the early chronic stage (10-15 days after symptom onset); and 23 at the late chronic stage (30-31 days after symptom onset). K trans maps were derived according to the method described in detail by Johnson et al. 10 It allows simultaneous mapping of the K trans and the plasma volume fraction (v p ) of the whole brain tissues. 7, 11 We placed the region of interest in the lesion area with maximal abnormality as determined from the K trans maps at the first examination of the patient. The corresponding v p also was measured in the same location. A homologous area in the normal-appearing contralateral hemisphere with similar size of region of interest was drawn as the referenced standard. All the regions of interest were applied to the subsequent follow-up images at the corresponding locations for each patient.
PE was defined as the presence of a hyperintense area on the K trans map, v p , or contrast enhancement on CET1-WI within the region of hyperintensity shown on diffusion-weighted images. 12 The presence of HT was evaluated by examining the region of infarct for hyperattenuation indicative of blood products on the noncontrast computed tomography or low signal intensity indicative of magnetic susceptibility from deoxyhemoglobin or methemoglobin on the T2*-weighted or diffusion-weighted image b 0 images. 2 The degree of enhancement on CET1-WI was expressed as rT1, a ratio of mean signal intensity of a region of interest on the infarction to that of the contralateral homologous normal brain area.
Statistical Analysis
Pairwise comparisons of K trans and v p measurements between lesion and normal-appearing contralateral areas from the perfusion imaging data were performed using Wilcoxon rank sum test. The correlation between parametric variables of K trans and v p was assessed using the Pearson correlation coefficient at 3 subdivided periods, including periods of hyperacute to acute stages, early subacute to late chronic stages, and hyperacute to late chronic stages. 
Discussion
In this study, we investigated longitudinal evolution of BBB derangements up to 1 month in patients with acute ischemic infarcts and spontaneous reperfusion using fpT2*-based K trans map, along with v p and CET1-weighted images. Our results showed high sensitivity of K trans map in detecting abnormal PE at acute stages of infarct as compared with v p and CET1-weighted images. These abnormally enhanced areas shown on K trans maps at acute stages were consistent with the final infarct areas with BBB disruption seen on CET1-WI at chronic stages. Patients with HT had higher occurrence rate of K trans PE and mean K trans values as compared with patients without HT. We observed no significant differences in v p measurements between the HT and the non-HT patient groups.
Theoretically, ischemic tissue can be salvaged by rapid restoration of cerebral flow, the reperfusion. However, controversy remains regarding whether reperfusion is totally beneficial to ischemic brain tissue. 13, 14 Stroke with reperfusion phenomenon could cause endothelial injury by inducing the secretion of strong vasodilatory substances.
14 Our results are in concert with the notion that reperfusion-induced BBB derangements could lead to subsequent HT, and the degree of BBB derangements adds to the risk of HT. PE shown on CET1-WI after ischemic stroke is generally accepted as an indicator of BBB disruption with extravasation of contrast material. However, this phenomenon usually starts to be observed at the late ischemic phase (usually ≥7 days after stroke), suggesting a leakage of small molecular contrast medium from the intravascular spaces to the extravascular spaces, which leads to PE occurring at a time when BBB disruption is severe enough to be observed by CET1-WI. 6 This hypothesis was tested by a previous study using continuous intravenous infusion of gadolinium in acute infarction. The study demonstrated that PE could occur in the acute stage if the contrast medium was administered continuously >2 hours rather than a clinically-used rapid bolus administration. 6 The absence of PE in CET1-WI during acute ischemic stroke, when using rapid bolus injection, should not be regarded as a result of intact BBB. In fact, the disturbance of the BBB is thought to be present as early as 6 hours after cerebral infarction. 6 Although the presence of collateral intravascular enhancement on CET1-WI can be detected immediately after the onset of stroke, it is somewhat lacking of specificity. It remains unclear whether the intravascular enhancement is related to the mechanism of BBB derangement or PE. 3, 6 As shown in our study, the microvascular permeability changes as translated by the K trans constant may serve as an indicator of significant ischemic injury of the brain. The areas delineated by the K trans parenchymal changes at acute stages were consistent with the CET1-WI PE area seen at chronic stages. However, the ischemic microvascular injury is not necessarily correlated with autoregulatory response, such as vessel dilatation and the resultant increase in regional blood volume, the luxury perfusion. Our results showed no correlation between K trans and v p measurements in acute ischemic stroke with reperfusion. The discrepancy between K trans and v p suggests different pathophysiologic processes in response to ischemia in terms of microvascular permeability versus cerebral blood volume, which exert different effects on the pharmacokinetic parameters. K trans provides information on the underlying pathophysiological changes of vascular permeability, 10 which potentially can be used to define the ischemic areas with disturbed BBB according to the abnormal kinetic behaviors, even when there is no significant change of cerebral blood volume shown in v p maps. This is particularly important for patients with stroke with spontaneous reperfusion phenomenon, in whom cerebral blood volume can be normal but significant ischemic injury has already begun. 13 In contrast to the inconsistent trend of v p and K trans at acute stages, we found a significant correlation between the 2 parameters during the period from the early subacute to the late chronic stage. Both v p and K trans reached their peak values at the late subacute stage and then attenuated progressively at early and late chronic stages. The increased values of v p during early and late subacute stages coincided with a previous report that hyperperfusion phenomenon typically occurs in the subacute phase (≥72 hours after the onset of symptoms). 13 It can be associated with the marked opening of the BBB and, therefore, supports the rationale for the significant correlation between v p and K trans during these subacute stages. The decrease of v p and K trans values at the chronic stage is in line with the known limitations of pharmokinetic model that K trans may be affected not only by endothelial permeability surface area product but also by blood flow perfusion efficiency, 10 whereby the reduction of blood flow perfusion at the chronic stage would give rise to the pseudorepaired BBB phenomenon (with K trans recovery) in brain infarction. It is, therefore, clear that CET1-WI still has an important role in detecting BBB leakage in patients with chronic ischemic stroke. Our study demonstrated that the typical PE seen on standard CET1-WI started to occur during the prominent luxury perfusion (high v p ) stage when the postischemic microvascular changes have already built-up early during the acute stage.
HT is often a natural evolution of ischemic stroke and generally is thought to arise from ischemic damage to BBB followed by reperfusion.
2,15 HT may not always be symptomatic. Symptomatic HT, usually because of parenchymal hematoma, is potentially devastating. It would be helpful if the noninvasive imaging method can provide additional information on the risk of HT, thus helping the selection of candidates for thrombolytic therapy. 2 In our patients, the occurrence of HT increased with higher K trans PE and values as compared with those without HT, which is in parallel with previous studies. 2, 4, 8, 9, 13, [15] [16] [17] [18] It is to be noted that although there is distinction in the occurrence rates of K trans PE for patients without and with HT, the presence of K trans PE should not be used to predict subsequent HT because of the low prediction specificity (Table  II in the online-only Data Supplement). In particular, the limited number of HT cases and the fact that all our patients had early spontaneous but not thrombolytic reperfusion precluded recruitment of more patient cases, including those with late reperfusion and severe BBB breakdowns. Spontaneous reperfusion in some patients with stroke has been reported to be nutritional and to have better clinical outcome. 19 Our results could have been affected by the specific inclusion and exclusion criteria adopted in this study. 15 Our study has several possible limitations. First, K trans may be underestimated if the cerebral blood flow is severely attenuated at acute ischemic stages. However, it is obvious that such an approach, which confirms and extends previous observations on the potential of pharmacokinetic calculations to provide a better characterization of stroke-related tissue changes at acute stages, only can be applied to patients with reperfusion phenomenon. Second, some investigators have argued whether the first-pass model, as opposed to slow infusion or delayed imaging, is truly measuring capillary endothelia permeability. 20 Nonetheless, methods that acquire data with prolonged image scanning during the washout of contrast material often require data collection over minutes and more flow effects from the second pass thus would contaminate the K trans measurements. In tumors, it has been reported that typically 12% to 45% of the contrast media leaks into the extravascular-extracellular space during the first pass, 21 which includes the arrival of contrast medium and lasts for a few cardiac cycles. 22 The first-pass pharmacokinetic model we used in this study has been previously demonstrated to yield a significant correlation with the steady-state T1-weighted method (ssT1). 7 Still, evidence from previous measurements prove that permeability-related measurements derived from the perfusion-weighted imaging with first-pass analysis can be diagnostically useful in brain tumors and ischemic stroke. 2, 10, 11, 17, 18, 23 Nonetheless, limitation may be that the data acquired during the first pass of the bolus could not fully reflect the changes of K trans measurements that connote the BBB permeability changes. Third, considering the paramagnetic effects of MR contrast agents to cause increase in T1 and T2 relaxation rates, the signal drop in T2* dynamic series will be possibly reduced in regions where T1 effects are significant. That is why the postcontrast signal baseline may be above the precontrast baseline. 10 In our study, however, we did not observe this severe T1 effect, even under the relatively higher flip angle used in our perfusion-weighted imaging pulse sequence. 10 Finally, it is known that K trans inherently has low resistance to noise, which is a common problem for K trans calculations in most pharmacokinetic model analyses. 24 Therefore, image quality threshold is theoretically critical for the clinical use, especially for the case of pixel-by-pixel mapping in routine practice.
In conclusion, our data showed that the T2*-based first-pass pharmacokinetic model seems to be more sensitive than conventional CET1-WI in detecting early microvascular permeability changes at the acute stage of ischemic stroke. Patients with HT showed higher K trans PE occurrence rate and values as compared with those without HT in the present study.
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Subjects
This was a retrospective study in a cohort of patients who had acute ischemic stroke admitted to Tri-Service General Hospital between August 2000 and April 2004. Data analysis of this study was approved a waiver of informed consent by a local institutional review board. Twenty-eight out of 127 patients who had acute stroke met the following criteria: 1) had acute ischemic infarcts of the unilateral middle cerebral arterial territory with early reperfusion determined by MR angiography at acute stage, 2) at least three MR follow-up perfusion-weighted imaging (PWI) and CET1-WIs were available respectively at acute, subacute, and chronic stages, 3) no thrombolytic therapy was administered. Two subjects who met the above criteria were excluded from the study due to suboptimal image quality; one was due to severe signal loss in region of infarct on PWI measurements and the other had severe unconscious movements during MR examination. Finally, data from 26 patients were enrolled in this study, these including 13 men and 13 women with ages ranging from 34 to 81 years (mean=56.10 years, STD=17.48 years). There were totally 101 MR examinations collected from the 26 patients; seven were obtained at the hyperacute stage (< 6 hours after symptom onset); 15 at the acute (6-48 hours after symptom onset); 19 at the early subacute (3-4 days after symptom onset); 19 at the late subacute (7-9 days after symptom onset); 18 at the early chronic stage (10-15 days after symptom onset); and 23 at the late chronic stage (30-31 days after symptom onset) (online-only Data Supplemental Table S1 ).
Magnetic Resonance Imaging
All MR imagings were performed at a 1.5T system (Magnetom Vision Plus system; Siemens, Erlangen, Germany). Unenhanced axial T1-weighed images were first While the K trans calculation is based on the steady-state T1-weighted method (ssT1), the first-pass T2*-weighted (fpT2*) perfusion imaging may gain more ground in clinical environment due to its wide adoption in acute stroke imaging for perfusion study [1] [2] [3] [4] [5] . K trans measurement based on the fpT2* method has been shown to have a potential for prediction of hemorrhagic transformation (HT) during the acute phase of stroke [1] [2] [3] [4] . In this study, we conducted a longitudinal follow-up study of K trans based on the fpT2* method. T2* susceptibility-based PWI (TR/TE = 1000/44 ms, matrix = 128 
Image analysis
K trans maps were derived according to the method described in detail by Johnson et al 5 . The dynamic concentration-time curve for brain tissue following contrast administration, C t (t), can be described by the equation:
where C p is the tracer concentration in the plasma, and v e is the volume fraction of the extravascular-extracellular space. The plasma concentration, which is associated with the arterial input and recirculation, is estimated by employing the vascular contrast medium concentration obtained from the normal-appearing contralateral white matter 5 . This model allows simultaneous mapping of the endothelial transfer constant, K trans , and the plasma volume fraction, v p , of the whole brain tissues 6, 7 . Although measurement of BBB K trans requires several assumptions which may not be true in complex ischemic brain environment and thus limit the absolute quantification of K trans , this method was shown to yield good correlation with the ssT1 method in brain tumor 1, 6 .
Because of the different contributions of perfusion baseline values from the gray and white matter areas in K trans measurements, we focused our measurements on the white matter areas in this study. Previous studies of PWI-derived parametric maps have shown that measurement of maximal abnormality provides the highest intra-and inter-observer reproducibility 7, 8 . We therefore placed the ROI in the lesion area with maximal abnormality as visually determined from the K trans maps at the first examination of the patient. The corresponding v p was also measured in the same location. The size of the ROI was kept as constant as possible (typically containing 25~30 pixels) to minimize confounding factors in ROI analyses 5, 7 . A homologous area in the normal-appearing contralateral white matter with similar size of ROI was drawn as the referenced standard to ensure that our calculated values are in reasonable agreement with the literatures 5, 9 . All the ROIs were applied to the subsequent follow-up images at the corresponding locations for each patient.
The presence of parenchymal enhancement (PE) and HT in lesion areas was The degree of enhancement on CET1-WI was expressed as rT1, a ratio of mean signal intensity of an ROI on the infarction to that of the contralateral homologous normal brain area. Time course of rT1 was obtained from the follow-up images at different stroke stages using the same-size ROI as for the acute image. were further compared between these two groups by using the Fisher exact test.
Statistical Analysis
Binary logistic regression models were used to predict HT outcomes (coded as 1 for HT and 0 for non-HT) using K trans PE (coded as 1 for PE and 0 for non-PE) and 
